Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Brain immune cells mediate arthritic joint pain

Aug. 16, 2018

Izana Bioscience begins phase II proof-of-concept study of namilumab in ankylosing spondylitis

Aug. 14, 2018

New Janus kinase inhibitors synthesized at Leo Pharma

Aug. 14, 2018

Council of Scientific and Industrial Research divulges caerulomycin A analogues

Aug. 14, 2018

OrthoTrophix presents phase II results for TPX-100 in patients with knee osteoarthritis

Aug. 14, 2018

First patient treated in phase Ib study of resiniferatoxin for OA knee pain

Aug. 14, 2018

The exerkine apelin reverses age-associated sarcopenia

Aug. 9, 2018

U.S. researchers identify ITGA5 antagonists

Aug. 8, 2018

Clover Biopharmaceuticals begins phase I study of etancercept biosimilar SCB-808

Aug. 2, 2018

New arthritis severity gene id'd

Aug. 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026